English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51924666    線上人數 :  1044
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lu y s"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 211-235 / 467 (共19頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-15T06:27:34Z Distant metastasis in triple-negative breast cancer Tseng L.M.; Hsu N.C.; Chen S.C.; Lu Y.S.; Lin C.H.; DWANG-YING CHANG; Li H.; Lin Y.C.; Chang H.K.; Chao T.C.; Ouyang F.; Hou M.F.
臺大學術典藏 2021-03-15T06:27:34Z Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; DWANG-YING CHANG; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏 2021-03-15T06:27:33Z Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; DWANG-YING CHANG; Huang C.-S.; Cheng A.L.
臺大學術典藏 2021-03-15T06:27:33Z The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines Chen W.-W.; DWANG-YING CHANG; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-03-15T06:27:32Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; DWANG-YING CHANG; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-03-15T06:27:31Z A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer Chen T.W.-W.; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; DWANG-YING CHANG; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer Consortium
臺大學術典藏 2021-03-15T06:27:31Z TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays Lin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG; Wang M.-Y.; Chang C.-H.; Chen W.-W.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2021-03-15T06:27:30Z A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; DWANG-YING CHANG; Lu Y.-S.; Huang C.-S.; Cheng A.-L.; Lin C.-H.; Chen P.-C.
臺大學術典藏 2021-03-15T06:27:30Z Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival Chen T.W.-W.; Jan I.-S.; DWANG-YING CHANG; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-03-12T00:50:54Z Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis Chen I.-C.; Lin C.-H.; I-SHIOW JAN; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-03-12T00:50:51Z Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival Chen T.W.-W.; I-SHIOW JAN; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.
臺大學術典藏 2021-03-10T05:34:20Z Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Ta-Chen Huang; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L.
臺大學術典藏 2021-03-09T05:18:40Z Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract Hsu C.; Ying-Chun Shen; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏 2021-03-09T05:18:38Z Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-03-09T05:18:38Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Ying-Chun Shen; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏 2021-03-05T06:07:34Z Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer Ch'ang H.-J.; Wang C.-C.; Cheng A.-L.; Hsu C.; Lu Y.-S.; MING-CHU CHANG; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-02-23T08:26:44Z Recent advances in the management of primary breast cancers Lu Y.-S.;Sung-Hsin Kuo;Huang C.-S.; Lu Y.-S.; SUNG-HSIN KUO; Huang C.-S.
臺大學術典藏 2021-02-23T08:26:44Z Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma Lu Y.-S.;Hsu C.;Li C.-C.;Sung-Hsin Kuo;Yeh K.-H.;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; SUNG-HSIN KUO; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.
臺大學術典藏 2021-02-23T08:26:42Z Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer Yeh K.-H.;Lu Y.-S.;Hsu C.-H.;Lin J.-F.;Hsu C.;Sung-Hsin Kuo;Li Jr. S.;Cheng A.-L.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; SUNG-HSIN KUO; Li Jr. S.; Cheng A.-L.
臺大學術典藏 2021-02-23T08:26:41Z Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors Lu Y.-S.;Lien H.-C.;Yeh P.-Y.;Yeh K.-H.;Kuo M.-L.;Sung-Hsin Kuo;Cheng A.-L.; Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Yeh K.-H.; Kuo M.-L.; SUNG-HSIN KUO; Cheng A.-L.
臺大學術典藏 2021-02-23T08:26:40Z Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity Lu Y.-S.;Lien H.-C.;Yeh P.-Y.;Sung-Hsin Kuo;Chang W.-C.;Kuo M.-L.;Cheng A.-L.; Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; SUNG-HSIN KUO; Chang W.-C.; Kuo M.-L.; Cheng A.-L.
臺大學術典藏 2021-02-23T08:26:39Z Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients Sung-Hsin Kuo;Lien H.-C.;You S.-L.;Lu Y.-S.;Lin C.-H.;Chen T.-Z.;Huang C.-S.; SUNG-HSIN KUO; Lien H.-C.; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; Huang C.-S.
臺大學術典藏 2021-02-23T08:26:37Z The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Huang C.-S.;Sung-Hsin Kuo;Lien H.-C.;Yang S.-Y.;You S.-L.;Shen C.-Y.;Lin C.-H.;Lu Y.-S.;Chang K.-J.; Huang C.-S.; SUNG-HSIN KUO; Lien H.-C.; Yang S.-Y.; You S.-L.; Shen C.-Y.; Lin C.-H.; Lu Y.-S.; Chang K.-J.
臺大學術典藏 2021-02-23T08:26:35Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; SUNG-HSIN KUO; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L.
臺大學術典藏 2021-02-23T08:26:34Z Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy Lin C.-H.;Lien H.-C.;Hu F.-C.;Lu Y.-S.;Sung-Hsin Kuo;Wu L.-C.;You S.-L.;Cheng A.-L.;Chang K.-J.;Huang C.-S.; Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; SUNG-HSIN KUO; Wu L.-C.; You S.-L.; Cheng A.-L.; Chang K.-J.; Huang C.-S.

顯示項目 211-235 / 467 (共19頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目